Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...

A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...

A decades-old label has scared women (and their doctors) away from safe and effective menopause treatment. That could finally change today.

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

Bioidentical or plant-derived hormones have uncertain efficacy or safety in treating menopausal symptoms. What is the evidence supporting the use of compounded and FDA-approved bioidentical products?

While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...